Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-12
2011-12-13
Aulakh, Charanjit (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S041000
Reexamination Certificate
active
08076351
ABSTRACT:
Novel camptothecin derivatives having antitumor activity, the processes for the preparation thereof, the use thereof as antitumor drugs and pharmaceutical compositions containing them.
REFERENCES:
patent: 5834479 (1998-11-01), Terasawa et al.
patent: 5972955 (1999-10-01), Duvvuri et al.
patent: 6177439 (2001-01-01), Duvvuri et al.
patent: 6214836 (2001-04-01), Duvvuri et al.
patent: 6265413 (2001-07-01), Jew et al.
patent: 0066127 (2000-11-01), None
Sugimori et al., “Antitumor Agents VI Synthesis and Antitumor Activity of Ring A-, Ring B-, and Ring C-Modified Derivatives of Camptothecin”, Heterocycles 38(1):81-94 (1994).
Allegri, legal representative Maria Grazia
Battaglia Arturo
Bombardelli Ezio
Fontana Gabriele
Manzotti Carla
Aulakh Charanjit
Indena S.p.A.
Porzio, Bromberg & Newman P.C.
LandOfFree
Camptothecin derivatives with antitumor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Camptothecin derivatives with antitumor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Camptothecin derivatives with antitumor activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4303724